Biodesix (BDSX) Short term Debt (2021 - 2024)

Biodesix has reported Short term Debt for 4 years, with the latest figure at $5.8 million in Q2 2024.

• For the quarter ending Q2 2024, Short term Debt fell 59.91% year-over-year to $5.8 million; the trailing twelve-month figure through Jun 2024 stood at $5.8 million (down 59.91% YoY), and the FY2023 full-year result was $21.9 million, up 111.36% from the prior year.
• Short term Debt for Q2 2024 stood at $5.8 million, down from $19.2 million in the prior quarter.
• The five-year high for Short term Debt was $21.9 million in Q4 2023, with the low at $5.8 million in Q2 2024.
• Historically, Short term Debt has averaged $13.7 million across 4 years, with a median of $13.1 million in 2021.
• Annual changes were most pronounced in 2023 — Short term Debt jumped 111.36% — and 2024, when it plunged 59.91%.
• Biodesix's Short term Debt stood at $17.8 million in 2021, then tumbled by 41.79% to $10.3 million in 2022, then jumped by 111.36% to $21.9 million in 2023, then tumbled by 73.29% to $5.8 million in 2024.
• The last three Short term Debt figures came in at $5.8 million (Q2 2024), $19.2 million (Q1 2024), and $21.9 million (Q4 2023), per Business Quant data.